Daito Pharmaceutical: Notice regarding changes in executive officers
Daito Pharmaceutical: Notice regarding the status and completion of share buybacks
Daito Pharmaceutical: Treasury stock purchase status report (based on Act Section 24-6 (1))
Daito Pharmaceutical: Change Report (Stock Certificates Eligible for Special Provisions, etc.)
Daito Pharmaceutical: Notice regarding the status of share buybacks
Daito Pharmaceutical: Correction Report (Mass Ownership Report/Change Report)
Dite: Confirmation
Daito: Quarterly Report - 82nd Quarter 3rd Quarter (2023/12/01 - 2024/02/29)
Daito Pharmaceutical: Summary of Financial Results for the 3rd Quarter Ending May 2024 [Japanese GAAP] (Consolidated)
Daito Pharmaceutical: Supplementary explanation materials for the announcement of financial results for the 3rd quarter of the fiscal year ending 2024/5
Daito Pharmaceutical: Notice Concerning Decisions on Matters Relating to Repurchase of Treasury Shares
Daito: Change Report (Stock Certificates Subject to Special Cases, etc.)
Daito Pharmaceutical: Notice regarding the second phase construction of the 10th Pharmaceutical Building
Daito Pharmaceutical: Notice regarding completion of the General Research Center
Daito Pharmaceutical: Corporate Governance Report 2024/02/09
Daito: treasury stock purchase status report (based on section 24-6 (1) of the Act)
Daito Pharmaceutical: Notice regarding completion of cancellation of treasury stock
Daito Pharmaceutical: Mass holding report (stock certificates subject to special cases, etc.)
Daito Pharmaceutical: Notice regarding the results of treasury stock acquisition and termination of share repurchase through an off-site share repurchase transaction (ToSTNet-3)
Daito Pharmaceutical: Extraordinary Report
No Data